Implementation strategies are now needed to get polypills into the hands of more patients, particularly in poorer countries.

Cardiovascular disease (CVD) is responsible for up to 25% of premature deaths in the UK, 80% of which are preventable. We explore the role integrated care systems could play in scaling up the ...

Baxdrostat meets primary and all secondary endpoints in BaxHTN phase III trial in patients with uncontrolled or treatment resistant hypertension: Cambridge, UK Wednesday, July 16, ...

AstraZeneca announced that baxdrostat, a selective aldosterone synthase inhibitor, met its primary and all secondary endpoints in the BaxHTN Phase III trial, effectively lowering blood pressure ...

AstraZeneca Vietnam has been honoured in the Outstanding CSR Activities category at the 2025 Top 50 Corporate Sustainability ...

Background Restarting direct oral anticoagulants (DOACs) after a serious bleeding event in patients with atrial fibrillation ...

We appreciate the opportunity to address the comments by Yangfan Cheng and colleagues, and Sebastian Walsh and colleagues regarding our Article on long-term gantenerumab treatment in dominantly ...

Compassion fatigue can affect those who have turned their pain into purpose. Sometimes we have to come off the front lines of ...

After combining three health behaviors and four health factors into a single cardiovascular health score, the AHA has ...

A new risk prediction tool developed by the American Heart Association (AHA) estimated cardiovascular disease (CVD) risk in a ...

Optimal heart health from birth through adolescence, as measured by a combination of metrics, leads to long-lasting cardiovascular and overall physical, cognitive and mental health, according to the ...

The prevalence of ideal CV health metrics varies across populations, but even modest improvement may help mitigate the ...